BRPI0508895A - formas polimorficas e amorfa de {2-flúor-5-[3-((e)-2-piridn-2-il-vinil)-1h-indazol-6-ilamin]- fenil}-amida de ácido 2,5-dimetil-2h-pirazol-3-carboxìlico - Google Patents
formas polimorficas e amorfa de {2-flúor-5-[3-((e)-2-piridn-2-il-vinil)-1h-indazol-6-ilamin]- fenil}-amida de ácido 2,5-dimetil-2h-pirazol-3-carboxìlicoInfo
- Publication number
- BRPI0508895A BRPI0508895A BRPI0508895-0A BRPI0508895A BRPI0508895A BR PI0508895 A BRPI0508895 A BR PI0508895A BR PI0508895 A BRPI0508895 A BR PI0508895A BR PI0508895 A BRPI0508895 A BR PI0508895A
- Authority
- BR
- Brazil
- Prior art keywords
- indazol
- phenyl
- vinyl
- pyridn
- pyrazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
FORMAS POLIMORFICAS E AMORFA DE {2-FLúOR-5-¢3-((E)-2-PIRIDN-2-IL-VINIL)-1 H-INDAZOL-6-LAMIN!-FENIL}-AMIDA DE áCIDO 2,5-DIMETIL-2H-PIRAZOL-3-CARBOXiLICO. A invenção provê várias formas polimárficas e uma forma amorfa de {2-flúor-5-¢3-((E)-2-piridin-2-iI-viniI)-1 H-indazol-6-ilamino!-fenil}-amida de ácido 2,5-dimetil-2H-pirazol-3-carboxílico, composições farmacêuticas contendo tais formas poumórficas e amorfas, e métodos de uso de tais composições farmacêuticas para tratamento de estados de doenças mediados por prote¢nas cinases, tais como câncer e outros estados de doenças associados com indesejada angiogênese e/ou proliferação celular.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55414004P | 2004-03-17 | 2004-03-17 | |
PCT/IB2005/000616 WO2005090331A1 (en) | 2004-03-17 | 2005-03-04 | Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indasol-6-ylamino]-phenyl}-amide |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0508895A true BRPI0508895A (pt) | 2007-09-11 |
Family
ID=34961166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0508895-0A BRPI0508895A (pt) | 2004-03-17 | 2005-03-04 | formas polimorficas e amorfa de {2-flúor-5-[3-((e)-2-piridn-2-il-vinil)-1h-indazol-6-ilamin]- fenil}-amida de ácido 2,5-dimetil-2h-pirazol-3-carboxìlico |
Country Status (16)
Country | Link |
---|---|
US (1) | US20050267158A1 (pt) |
EP (1) | EP1745035A1 (pt) |
JP (1) | JP2007529500A (pt) |
KR (1) | KR100816960B1 (pt) |
CN (1) | CN1930148A (pt) |
AR (1) | AR048268A1 (pt) |
AU (1) | AU2005223486A1 (pt) |
BR (1) | BRPI0508895A (pt) |
CA (1) | CA2559639A1 (pt) |
CO (1) | CO5721003A2 (pt) |
IL (1) | IL177434A0 (pt) |
NO (1) | NO20064675L (pt) |
RU (1) | RU2324692C1 (pt) |
TW (1) | TW200600511A (pt) |
WO (1) | WO2005090331A1 (pt) |
ZA (1) | ZA200606719B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006043172A1 (en) * | 2004-10-19 | 2006-04-27 | Pfizer Inc. | Pharmaceutical compositions and methods for sub-tenon delivery |
WO2007061849A2 (en) * | 2005-11-23 | 2007-05-31 | Merck & Co., Inc. | Method of generating amorphous solid for water-insoluble pharmaceuticals |
JO3062B1 (ar) * | 2010-10-05 | 2017-03-15 | Lilly Co Eli | R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري |
WO2017218365A1 (en) * | 2016-06-16 | 2017-12-21 | Sunshine Lake Pharma Co., Ltd. | Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI262914B (en) * | 1999-07-02 | 2006-10-01 | Agouron Pharma | Compounds and pharmaceutical compositions for inhibiting protein kinases |
-
2005
- 2005-03-04 KR KR1020067019062A patent/KR100816960B1/ko not_active IP Right Cessation
- 2005-03-04 JP JP2007503434A patent/JP2007529500A/ja not_active Withdrawn
- 2005-03-04 WO PCT/IB2005/000616 patent/WO2005090331A1/en not_active Application Discontinuation
- 2005-03-04 EP EP05708711A patent/EP1745035A1/en not_active Withdrawn
- 2005-03-04 BR BRPI0508895-0A patent/BRPI0508895A/pt not_active IP Right Cessation
- 2005-03-04 AU AU2005223486A patent/AU2005223486A1/en not_active Abandoned
- 2005-03-04 RU RU2006133291/04A patent/RU2324692C1/ru not_active IP Right Cessation
- 2005-03-04 CN CNA2005800082833A patent/CN1930148A/zh active Pending
- 2005-03-04 CA CA002559639A patent/CA2559639A1/en not_active Abandoned
- 2005-03-14 TW TW094107724A patent/TW200600511A/zh unknown
- 2005-03-15 US US11/081,708 patent/US20050267158A1/en not_active Abandoned
- 2005-03-15 AR ARP050101001A patent/AR048268A1/es not_active Application Discontinuation
-
2006
- 2006-08-10 IL IL177434A patent/IL177434A0/en unknown
- 2006-08-14 ZA ZA200606719A patent/ZA200606719B/en unknown
- 2006-09-14 CO CO06092571A patent/CO5721003A2/es not_active Application Discontinuation
- 2006-10-16 NO NO20064675A patent/NO20064675L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20050267158A1 (en) | 2005-12-01 |
IL177434A0 (en) | 2006-12-10 |
KR20060124769A (ko) | 2006-12-05 |
ZA200606719B (en) | 2007-12-27 |
AU2005223486A1 (en) | 2005-09-29 |
KR100816960B1 (ko) | 2008-03-25 |
CA2559639A1 (en) | 2005-09-29 |
TW200600511A (en) | 2006-01-01 |
JP2007529500A (ja) | 2007-10-25 |
CO5721003A2 (es) | 2007-01-31 |
NO20064675L (no) | 2006-11-28 |
AR048268A1 (es) | 2006-04-12 |
WO2005090331A1 (en) | 2005-09-29 |
EP1745035A1 (en) | 2007-01-24 |
CN1930148A (zh) | 2007-03-14 |
RU2324692C1 (ru) | 2008-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0513477A (pt) | composições e processos de uso de proteìna 4 semelhante a angiotensina | |
BR112012006252A2 (pt) | "formas cristalinas de abt-263 e solvatos para o uso no tratamento de doenças relacionadas á proteína bcl-2". | |
CL2004001069A1 (es) | Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii. | |
CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
BRPI0607988A2 (pt) | composto, composição farmacêutica, e método para induzir apoptose em uma célula | |
EA201300330A1 (ru) | Антагонисты активина-actriia и их применение для стимулирования роста кости | |
WO2007007173A3 (en) | Human anti-madcam antibodies | |
BRPI0508390B8 (pt) | uso de um anticorpo antagonista anti-ngf, bem como kit e composição farmacêutica para tratamento de dor de câncer de osso | |
BRPI0717219A2 (pt) | "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica." | |
BRPI0509172A (pt) | pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento | |
MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
BRPI0514537B8 (pt) | compostos de aminoeteroarila substituídos com pirazol e composição farmacêutica que os compreende | |
ECSP105178A (es) | Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos | |
ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
MXPA06003474A (es) | Agonistas de receptores de melanocortina. | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
BRPI0714844B8 (pt) | molécula de ácido nucleico e seus usos, composição farmaceutica e complexo | |
CL2008000021A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer. | |
WO2007059341A3 (en) | Pyrazolothiazole protein kinase modulators | |
CR9568A (es) | DERIVADOS DE PIRIDO[2,3-d]PIRIMIDINA, SU PREPARACION, SU APLICACION EN TERAPEUTICA | |
BRPI0411485A (pt) | peptìdeo derivado de rasgap para matar seletivamente células cancerosas | |
ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
BRPI0508895A (pt) | formas polimorficas e amorfa de {2-flúor-5-[3-((e)-2-piridn-2-il-vinil)-1h-indazol-6-ilamin]- fenil}-amida de ácido 2,5-dimetil-2h-pirazol-3-carboxìlico | |
ATE487721T1 (de) | Triaza-benzoäeüazulenderivate zur behandlung von tumoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |